Literature DB >> 15942444

A clinicopathologic study of primary adenosquamous carcinoma of the liver.

Michiya Kobayashi1, Takehiro Okabayashi, Ken Okamoto, Tsutomu Namikawa, Keijiro Araki.   

Abstract

BACKGROUND: Adenosquamous carcinoma (ASC) is a rare tumor of the liver, which carries a poor prognosis. In this study, we reviewed reported cases of ASC and examined their clinicopathologic features.
MATERIALS AND METHODS: A computer MEDLINE search found 65 histologically defined primary ASC cases reported in the literature from 1975 to 2003, including our case. Of these, detailed data were obtained for 42 cases, and these were subsequently investigated clinicopathologically.
RESULTS: Among the 42 cases, 34 were reported to have died of ASC and 5 cases were alive at the time of the study. The mean survival of these 34 cases was 8.7 months. Multivariate analysis revealed that lymph node metastasis and the elevation of total bilirubin were associated with poor survival after surgery, and lymph node metastasis, intrahepatic metastasis, location of tumor in the right lobe, and the pathologic stage were significant factors for all cases.
CONCLUSION: The current study highlights the prognostic factors of ASC of the liver, showing that the prognosis for patients with ASC is poor.

Entities:  

Mesh:

Year:  2005        PMID: 15942444     DOI: 10.1097/01.mcg.0000165705.74079.fc

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  10 in total

Review 1.  Primary adenosquamous carcinoma of the liver: a case report and review of the literature.

Authors:  Shengqiang Gao; Dongdong Chen; Lidong Huang; Ling Wu; Ruijie Dai; Yunfeng Shan
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

2.  Synchronous double cancers of primary hepatic adenosquamous carcinoma and hepatocellular carcinoma: report of a case.

Authors:  Seiichi Shimizu; Akihiko Oshita; Hirotaka Tashiro; Hironobu Amano; Tsuyoshi Kobayashi; Maiko Tanaka; Koji Arihiro; Hideki Ohdan
Journal:  Surg Today       Date:  2012-09-27       Impact factor: 2.549

3.  Primary adenosquamous carcinoma of the esophagus.

Authors:  Shao-Bin Chen; Hong-Rui Weng; Geng Wang; Jie-Sheng Yang; Wei-Ping Yang; Di-Tian Liu; Yu-Ping Chen; Hao Zhang
Journal:  World J Gastroenterol       Date:  2013-12-07       Impact factor: 5.742

Review 4.  Surgical outcome of carcinosarcoma of the gall bladder: a review.

Authors:  Takehiro Okabayashi; Zhao-Li Sun; Robert A Montgomey; Kazuhiro Hanazaki
Journal:  World J Gastroenterol       Date:  2009-10-21       Impact factor: 5.742

5.  Treatment and Survival Patterns of Primary Adenosquamous Carcinoma of the Liver: A Retrospective Analysis.

Authors:  Qiheng Gou; Shengya Fu; Yuxin Xie; Mengni Zhang; Yali Shen
Journal:  Front Oncol       Date:  2021-08-09       Impact factor: 6.244

6.  A case of primary adenosquamous carcinoma of the liver.

Authors:  Gu Hyum Kang; Byung Seok Lee; Dae Young Kang
Journal:  Korean J Hepatobiliary Pancreat Surg       Date:  2013-02-28

7.  The comparison of surgical patients with primary hepatic squamous cell carcinoma or adenosquamous carcinoma and surgical patients with hepatocellular carcinoma.

Authors:  Long Yan; Feng Xie; Cheng Yang; Lihan Yu; Tao Zheng; Jun Fu; Jiamei Yang
Journal:  World J Surg Oncol       Date:  2015-02-28       Impact factor: 2.754

8.  Primary adenosquamous carcinoma of the liver: a case report.

Authors:  Kyung Han Nam; Ji Yeon Kim
Journal:  Clin Mol Hepatol       Date:  2016-12

9.  Cholangiocarcinoma Presenting as Humoral Hypercalcemia of Malignancy: A Case Report and Literature Review.

Authors:  Burak Erdinc; Preethi Ramachandran; Ruchi Yadav; Sonu Sahni; Gardith Joseph
Journal:  Cureus       Date:  2019-12-27

Review 10.  Unresectable primary hepatic adenosquamous carcinoma successfully treated with systemic and transcatheter hepatic arterial injection chemotherapies followed by conversion surgery: a case report and literature review.

Authors:  Yusuke Watanabe; Akihiko Osaki; Kiwamu Kimura; Shunta Yakubo; Kenichi Takaku; Munehiro Sato; Hideki Hashidate; Nobuo Waguri; Shuji Terai
Journal:  BMC Gastroenterol       Date:  2021-12-20       Impact factor: 3.067

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.